Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
dailiport hart forðahylki 5 mg
sandoz a/s - tacrolimus monohydrate; tacrolimus - hart forðahylki - 5 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
dailiport hart forðahylki 0,5 mg
sandoz a/s - tacrolimus monohydrate; tacrolimus - hart forðahylki - 0,5 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
dailiport hart forðahylki 1 mg
sandoz a/s - tacrolimus monohydrate; tacrolimus - hart forðahylki - 1 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
dailiport hart forðahylki 2 mg
sandoz a/s - tacrolimus; tacrolimus monohydrate - hart forðahylki - 2 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
dailiport hart forðahylki 3 mg
sandoz a/s - tacrolimus monohydrate; tacrolimus - hart forðahylki - 3 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
prograf hart hylki 0,5 mg
astellas pharma a/s* - tacrolimusum mónohýdrat - hart hylki - 0,5 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
prograf hart hylki 1 mg
astellas pharma a/s* - tacrolimusum mónohýdrat - hart hylki - 1 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
prograf hart hylki 5 mg
astellas pharma a/s* - tacrolimusum mónohýdrat - hart hylki - 5 mg
Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
maviret
abbvie deutschland gmbh co. kg - glecaprevir, pibrentasvir - lifrarbólga c, langvinn - veirueyðandi lyf til almennrar notkunar - maviret is indicated for the treatment of chronic hepatitis c virus (hcv) infection in adults and children aged 3 years and older. maviret coated granules is indicated for the treatment of chronic hepatitis c virus (hcv) infection in children 3 years and older.
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
eplerenon bluefish filmuhúðuð tafla 25 mg
bluefish pharmaceuticals ab - eplerenonum inn - filmuhúðuð tafla - 25 mg